NCT00676026
Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
See it on ClinicalTrials.gov ↗Not reported
- Phase
- NA
- Paid for by
- University of Pennsylvania
- Finished
- 2009-02
- Health conditions
- Healthy
- Who could join
- Women only
- Ages
- 18 Years – 45 Years
- Average age
- Not reported
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 45 Years.”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Use of steroid contraceptives (any method involving hormones) within the previous 4 months;”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index 18.5 to 30 kg/m2;”
- No diabetes
Women with diabetes were turned away.
“Diabetes controlled by means other than diet;”
- No seizures
Women with epilepsy or past seizures were turned away.
“Medical, neurologic or cerebrovascular disorder (CVA, seizure disorder, etc.);”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Family history of first degree relative with an Axis I psychiatric or substance dependence disorder (excepting alcohol and nicotine) (per subject report);”
- No smokers
Women who smoke or use nicotine were turned away.
“Family history of first degree relative with an Axis I psychiatric or substance dependence disorder (excepting alcohol and nicotine) (per subject report);”
Study titles and rules are shown in their original English.